Treatment of Herpes Zoster
For uncomplicated herpes zoster (shingles), oral antiviral therapy with valacyclovir 1 gram three times daily for 7 days is the recommended first-line treatment. 1
Treatment Algorithm Based on Disease Severity
Uncomplicated Herpes Zoster
- First-line treatment: Valacyclovir 1 gram orally three times daily for 7 days 1, 2
- Alternative options:
- Treatment should be initiated within 72 hours of rash onset for maximum effectiveness 2, 4
- Continue treatment until all lesions have scabbed 1
Disseminated or Invasive Herpes Zoster
- Recommended treatment: Intravenous acyclovir 5-10 mg/kg every 8 hours 1
- Temporary reduction in immunosuppressive medication if applicable 1
- Continue treatment until clinical resolution is attained 1
- Switch to oral therapy once clinical improvement occurs 1
Special Populations
Immunocompromised Patients
- Valacyclovir 1 gram three times daily for 7 days is effective in immunocompromised patients 5
- Higher dosages (valacyclovir 2 grams three times daily) have not shown additional benefit 5
- Consider longer treatment duration if healing is delayed 1
- Monitor closely for dissemination and complications 1
Elderly Patients
- Valacyclovir has shown better efficacy than acyclovir in patients ≥50 years old 4
- Median duration of post-herpetic neuralgia is significantly reduced with valacyclovir (38 days) compared to acyclovir (51 days) 4
- Dosage adjustment may be needed for renal impairment 2
Clinical Benefits of Treatment
- Accelerates rash healing 4, 6
- Reduces acute pain during the eruptive phase 4, 6, 3
- Decreases the duration of post-herpetic neuralgia 4, 6
- Reduces the proportion of patients with persistent pain at 6 months (19.3% vs 25.7% with acyclovir) 4
Important Considerations
- Therapy is most effective when initiated within 48-72 hours of rash onset 2, 4
- However, treatment may still be beneficial when started later than 72 hours after rash onset, especially in patients with new lesion formation or immunocompromised status 3
- Treatment should be continued until all lesions have scabbed 1
- No significant benefit has been shown for extending acyclovir treatment beyond 7 days 7
Common Pitfalls and Caveats
- Failure to initiate treatment promptly (within 72 hours of rash onset) significantly reduces efficacy 2, 4
- Inadequate dosing frequency (valacyclovir offers simpler dosing than acyclovir) 4, 6, 3
- Not continuing treatment until all lesions have scabbed 1
- Antiviral therapy reduces but does not eliminate the risk of post-herpetic neuralgia 4, 3
- Not adjusting dosage in patients with renal impairment 2